OncoBay signs on with physIQ’s latest clinical trial program
17 Nov 2022 //
FIERCEBIOTECH
PhysIQ unveils partner program for CROs, other research groups
10 Nov 2022 //
FIERCEBIOTECH
physIQ Launches the Intrepid Partner Program
09 Nov 2022 //
BUSINESSWIRE
InCarda, PhysIQ and Syneos team for phase 3 flecainide study
31 Aug 2022 //
FIERCEBIOTECH
physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health
24 Aug 2022 //
BUSINESSWIRE